HELSINKI -- By Marianne Chang/Korea Biomedical Review correspondent – Under Daewoong Pharmaceutical’s C&D Innovation Team and cooperation with Business Finland, six Korean digital health companies visited Helsinki to showcase their latest innovations.
Daewoong Pharmaceutical was invited to the first Radical Health Festival Helsinki by Dr. Päivi Sillanaukee, Special Envoy for Health and Wellbeing at the Ministry of Social Affairs and Health.
“While Korea still stands in the early stages for DTx, some countries in the European Union already have lots of experience and real-world data for DTx use,” said Yang Sung-eun, Daewoong Pharmaceutical’s head of C&D Innovation, explaining the reason for coming to Finland.
On the sidelines of the Radical Health Festival Helsinki event, Korea Biomedical Review interviewed executives from eMotiv, BRLAB, Huniverse, Medi-IOT, B.I.G.S Spring Tree, and Neurive.
Jeong Min-young, Head of R&D at eMotiv, disclosed that the Finnish Ministry of Social Affairs and Welfare suggested three potential local game companies for collaboration. Additionally, a local medical consortium expressed interest in exploring future opportunities for supporting clinical trials and research.
Positive reactions to Korean digital health solutions
eMotiv showcased the healthcare edition of their digital therapeutics (DTx) device, Star Ruckus, which is currently in need of clinical trials. Designed to address attention deficit hyperactivity disorder (ADHD) in children aged 6 to 12 years, this DTx device can be conveniently downloaded from the Korean Android/iOS market without a prescription. In just 30 minutes, it allows for the assessment of cognitive abilities, including ADHD. Moreover, with consistent daily usage of approximately 25 minutes, it offers cognitive enhancement for children.
Similarly, Neurive is developing electroceuticals and digital therapeutics devices that utilize neuromodulation techniques, such as electrical stimulation and neurofeedback, for the treatment of degenerative brain diseases.
“Many expressed satisfaction after trying the device and we also gathered information from potential investors,” said Neurive CTO Choi Hyuk.
Neurive’s Chief Technology Officer Choi Hyuk demonstrates his digital health solution to an interested participant on Tuesday at the Helsinki Expo and Convention Centre.
BRLAB, a Korean start-up specializing in sleep technology, displayed its solutions for monitoring bio-signals and sleep status, improving sleep through bio-feedback, and providing coaching through data-based AI.
“As Finland has advanced digital healthcare technologies, especially in the field of sleep, we are seeking a clinical test partner in Finland for attaining European certification and a distribution partner,” said BRLAB CEO Lee Jong-min. “We found that there was a lot of interest in our technology, and we met a lot of great partners that we hope to collaborate with in the future.”